Autori: Mateos Maria-Victoria
| Naslov | Lighthouse: melflufen, daratumumab, and dexamethasone versus daratumumab in relapsed/refractory multiple myeloma refractory to an imid and a proteasome inhibitor or with ≥3 prior lines of therapy (Meeting Abstract) |
| Autori | Mateos Maria-Victoria Szarejko Monika Bila Jelena S Schjesvold Fredrik Spicka Ivan Maisnar Vladimir Jurczyszyn Artur Grudeva-Popova Zhanet Hajek Roman Usenko Hanna Thuresson Marcus Norin Stefan Jarefors Sara Richardson Paul Pour Ludek |
| Info | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, (2023), vol. 23 br. , Suppl. 2, str. S200-S201 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa |
| Naslov | Subcutaneous Daratumumab Plus Pomalidomide and Dexamethasone (D-Pd) Versus Pomalidomide and Dexamethasone (Pd) Alone in Patients with Relapsed or Refractory Multiple Myeloma (RRMM): Overall Survival Results from the Phase 3 Apollo Study (Meeting Abstract) |
| Autori | Dimopoulos Meletios A Terpos Evangelos Boccadoro Mario Delimpasi Sosana Beksac Meral Katodritou Eirini Moreau Philippe Baldini Luca Symeonidis Argiris Bila Jelena S Oriol Albert Mateos Maria-Victoria Einsele Hermann Orfanidis Ioannis Kampfenkel Tobias Liu Weiping Kosh Michele NamPhuong Tran Carson Robin Sonneveld Pieter |
| Info | BLOOD, (2022), vol. 140 br. , Suppl. 1, str. 7272-7274 |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
